terazosin has been researched along with Muscular Atrophy, Spinal in 1 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Muscular Atrophy, Spinal: A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyd, PJ | 1 |
Tu, WY | 1 |
Shorrock, HK | 1 |
Groen, EJN | 1 |
Carter, RN | 1 |
Powis, RA | 1 |
Thomson, SR | 1 |
Thomson, D | 1 |
Graham, LC | 1 |
Motyl, AAL | 1 |
Wishart, TM | 1 |
Highley, JR | 1 |
Morton, NM | 1 |
Becker, T | 1 |
Becker, CG | 1 |
Heath, PR | 1 |
Gillingwater, TH | 1 |
1 other study available for terazosin and Muscular Atrophy, Spinal
Article | Year |
---|---|
Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy.
Topics: Adenosine Triphosphate; Animals; Axons; Disease Models, Animal; Disease Susceptibility; Energy Metab | 2017 |